Trial intelligence / Profile preview

Technosphere Insulin vs Insulin Aspart in Type 1 Diabetes

NCT00539396Phase 2Completed

Sponsor
MannKind
Start
Mar 2005
Modality
Recombinant Proteins and Enzymes
01

Overview

A Phase 2 trial of Technosphere insulin in type 1 diabetes mellitus (T1D), sponsored by MannKind. Started Mar 2005; status: completed.

02

Drugs

Technosphere insulin
03

Conditions

type 1 diabetes mellitus (T1D)

Beyond the preview

Go deeper on NCT00539396.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00539396.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call